|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.15/--
|
企業價值
6.79B
|
資產負債 |
每股賬面淨值
-0.87
|
現金流量 |
現金流量率
--
|
損益表 |
收益
622.00K
|
每股收益
0.00
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/06 02:20 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe. |